CAM
SCLN

ClariVest Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

ClariVest Asset Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-47,191
Closed -$463K – 763
2017
Q1 		$463K Sell
47,191
-157,125
-77% -$1.57M 0.01% 394
2016
Q4 		$2.21M Buy
204,316
+9,154
+5% +$91.5K 0.06% 249
2016
Q3 		$2M Buy
195,162
+35,617
+22% +$388K 0.06% 214
2016
Q2 		$2.08M Buy
159,545
+16,600
+12% +$218K 0.06% 198
2016
Q1 		$1.57M Buy
142,945
+4,192
+3% +$37.3K 0.05% 231
2015
Q4 		$1.28M Sell
138,753
-109,363
-44% -$915K 0.04% 258
2015
Q3 		$1.72M Sell
248,116
-169,957
-41% -$1.46M 0.05% 202
2015
Q2 		$4.11M Buy
418,073
+33,851
+9% +$308K 0.12% 110
2015
Q1 		$3.4M Buy
384,222
+97,337
+34% +$775K 0.1% 132
2014
Q4 		$2.51M Buy
286,885
+393
+0.1% +$3.18K 0.09% 130
2014
Q3 		$1.98M Buy
+286,492
New +$1.72M 0.07% 179
2014
Q2 		– Sell
-3,253
Closed -$15K – 662
2014
Q1 		$15K Sell
3,253
-28,500
-90% -$138K ﹤0.01% 473
2013
Q4 		$160K Sell
31,753
-87,261
-73% -$420K 0.01% 378
2013
Q3 		$602K Buy
+119,014
New +$663K 0.03% 252

Other funds holding SCLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ClariVest Asset Management's SCLN Position: Q2 2017 in Review

ClariVest Asset Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q2 2017, closing a stake of 47,191 shares — an estimated $463K sold.

ClariVest Asset Management first reported a position in SCLN in Q3 2013 and held it in 14 quarters. The position peaked at $4.11M in Q2 2015. 142 funds tracked by Wall St. Rank hold SCLN as of Q2 2017.

  • ClariVest Asset Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • ClariVest Asset Management sold 47,191 Sciclone Pharmaceuticals Inc shares in Q2 2017, an estimated $463K.
  • ClariVest Asset Management first reported a position in Sciclone Pharmaceuticals Inc in Q3 2013 and held it in 14 quarters.
  • ClariVest Asset Management's Sciclone Pharmaceuticals Inc position peaked at $4.11M in Q2 2015.
  • 142 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q2 2017.

Based on ClariVest Asset Management's 13F filing for Q2 2017, filed 2 Aug 2017.